FDA ups tropical disease voucher fee
This article was originally published in Scrip
Executive Summary
The FDA is boosting the fee for its tropical disease priority review voucher for fiscal year (FY) 2015 to $2,562,000, which is up from $2,325,000 for the current year ending 30 September.